Employee-related Liabilities, Current of Allogene Therapeutics, Inc. from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: Allogene Therapeutics, Inc. quarterly Employee-related Liabilities, Current in USD history and change rate from 31 Dec 2021 to 31 Dec 2024.
Allogene Therapeutics, Inc. Employee-related Liabilities, Current for the quarter ending 31 Dec 2024 was $12,146,000, a 4.1% decline year-over-year.
Source SEC data: View on sec.gov

Employee-related Liabilities, Current, Quarterly (USD)

Employee-related Liabilities, Current, YoY Quarterly Change (%)

Allogene Therapeutics, Inc. Quarterly Employee-related Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$12,146,000	-$519,000	-4.1%	31 Dec 2024	10-K	13 Mar 2025	2024	FY
Q4 2023	$12,665,000	-$5,270,000	-29%	31 Dec 2023	10-K	13 Mar 2025	2024	FY
Q4 2022	$17,935,000	+$1,809,000	+11%	31 Dec 2022	10-K	14 Mar 2024	2023	FY
Q4 2021	$16,126,000			31 Dec 2021	10-K/A	14 Mar 2024	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.